79 related articles for article (PubMed ID: 17572007)
1. A cancer cell-specific inducer of apoptosis.
Green KL; Brown C; Roeder GE; Southgate TD; Gaston K
Hum Gene Ther; 2007 Jun; 18(6):547-61. PubMed ID: 17572007
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
Roeder GE; Parish JL; Stern PL; Gaston K
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
[TBL] [Abstract][Full Text] [Related]
3. Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy.
Green KL; Southgate TD; Mulryan K; Fairbairn LJ; Stern PL; Gaston K
Hum Gene Ther; 2006 Feb; 17(2):147-57. PubMed ID: 16454648
[TBL] [Abstract][Full Text] [Related]
4. HPV 16 E2 protein induces apoptosis in human and murine HPV 16 transformed epithelial cells and has antitumoral effects in vivo.
Bermúdez-Morales VH; Peralta-Zaragoza O; Guzmán-Olea E; García-Carrancá A; Bahena-Román M; Alcocer-González JM; Madrid-Marina V
Tumour Biol; 2009; 30(2):61-72. PubMed ID: 19390235
[TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway.
Webster K; Parish J; Pandya M; Stern PL; Clarke AR; Gaston K
J Biol Chem; 2000 Jan; 275(1):87-94. PubMed ID: 10617590
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy.
Wang W; Xia X; Wang S; Sima N; Li Y; Han Z; Gao Q; Luo A; Li K; Meng L; Zhou J; Wang C; Shen K; Ma D
Cancer Gene Ther; 2011 Nov; 18(11):825-36. PubMed ID: 21852812
[TBL] [Abstract][Full Text] [Related]
7. Addition of a single E2 binding site to the human papillomavirus (HPV) type 16 long control region enhances killing of HPV positive cells via HPV E2 protein-regulated herpes simplex virus type 1 thymidine kinase-mediated suicide gene therapy.
Sharma R; Palefsky JM
Hum Gene Ther; 2010 Jul; 21(7):843-54. PubMed ID: 20132050
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
[TBL] [Abstract][Full Text] [Related]
9. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis.
Sanchez-Perez AM; Soriano S; Clarke AR; Gaston K
J Gen Virol; 1997 Nov; 78 ( Pt 11)():3009-18. PubMed ID: 9367388
[TBL] [Abstract][Full Text] [Related]
11. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis.
Desaintes C; Demeret C; Goyat S; Yaniv M; Thierry F
EMBO J; 1997 Feb; 16(3):504-14. PubMed ID: 9034333
[TBL] [Abstract][Full Text] [Related]
12. Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein.
Sethi N; Palefsky J
Hum Gene Ther; 2003 Jan; 14(1):45-57. PubMed ID: 12573058
[TBL] [Abstract][Full Text] [Related]
13. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
14. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
[TBL] [Abstract][Full Text] [Related]
15. Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis.
Blachon S; Bellanger S; Demeret C; Thierry F
J Biol Chem; 2005 Oct; 280(43):36088-98. PubMed ID: 16135518
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the HPV-16 E2 transcriptional activator and p53.
Massimi P; Pim D; Bertoli C; Bouvard V; Banks L
Oncogene; 1999 Dec; 18(54):7748-54. PubMed ID: 10618715
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome.
Kurg R; Uusen P; Võsa L; Ustav M
Virology; 2010 Dec; 408(2):159-66. PubMed ID: 20940072
[TBL] [Abstract][Full Text] [Related]
19. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
20. Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP.
Wang W; Fang Y; Sima N; Li Y; Li W; Li L; Han L; Liao S; Han Z; Gao Q; Li K; Deng D; Meng L; Zhou J; Wang S; Ma D
Apoptosis; 2011 Jan; 16(1):55-66. PubMed ID: 20882347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
